Three members of the editorial board for Drug R&D (Research & Development) Expert participated in-person in the 15th DIA China Annual Meeting 2023 held in Suzhou, China from June 16th (Fri) to 19th (Mon), 2023.

On June 18th (Sun), We, Drug R&D Expert, in collaboration with DIA China, China Pharmaceutical Innovation and Research Development Association (PhIRDA) and China-Japan Medical and Material Technology Innovation Center (CJMMIC) held the only Japan-China joint session at the 15th DIA China 2023 titled “Japan as the next destination for Chinese biotech/biopharma – Demystify its hurdles/barriers” (拨开云雾，扫除障碍，⽇本为中国⽣物药企出海的下⼀站).

In this session, Mr. Tetsuomi Takano, Editor-in-Chief of Drug R&D Expert as well as Representative of t2T Healthcare, gave a presentation titled “Japan’s facts in current regulations and environments on PMDA consultations, clinical studies, NDAs and pharmaceutical markets” and also participated in a panel discussion.